Erdong Liu

Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy.

Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy.

Journal: Cancer letters
Published: October 11, 2025

HLF transactivates TFEB to promote gallbladder cancer stem cells' self-renewal and determines tumor response to distinct therapies.

HLF transactivates TFEB to promote gallbladder cancer stem cells' self-renewal and determines tumor response to distinct therapies.

Journal: Science advances
Published: August 08, 2025

ADCY7 dictates N-cadherin stability to inhibit HCC metastasis.

ADCY7 dictates N-cadherin stability to inhibit HCC metastasis.

Journal: JHEP reports : innovation in hepatology
Published: June 06, 2025

LAMC2 promotes gallbladder carcinoma metastasis through the TGF-β pathway.

LAMC2 promotes gallbladder carcinoma metastasis through the TGF-β pathway.

Journal: Cancer cell international
Published: May 27, 2025

Single-cell analysis reveals CD34+CD90+ endothelial cells promote tumor metastasis in gallbladder cancer.

Single-cell analysis reveals CD34+CD90+ endothelial cells promote tumor metastasis in gallbladder cancer.

Journal: NPJ precision oncology
Published: October 24, 2024

Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.

Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.

Journal: Journal of hematology & oncology
Published: October 07, 2024

Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression.

Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression.

Journal: Nature genetics
Published: July 13, 2024

Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC.

Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC.

Journal: Gut
Published: May 21, 2024

Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma.

Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma.

Journal: Pharmacological research
Published: October 12, 2022

Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.

Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.

Journal: Clinical and translational medicine
Published: May 19, 2022

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.

Journal: Cell discovery
Published: December 30, 2021

Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.

Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.

Journal: Clinical and translational medicine
Published: September 02, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026